Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications

NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. The recommendations from this working group are built upon and integrate the outcomes of previous working groups hosted by OCHMO.
Posted on September 22, 2026
Sign up for our newsletter:

Categories

209
14
11
30
2
2
1
46
10
1
49
3
14
3
2
1
4
2
3
2
14
4
3
1
3
20
3
1
16
6
6
1
7
3
361
21
1
1
7
1
5
1
279
38
232
10
1
1
1
62
3
13
17
1
10
9
Io
5
4
27
1
1
386
113
67
4
14
2
6
6
658
17
1
1
202
13
1
10
1
12
159
6
29
1

Blog Posts

Newsletter Archive